A panel at GAR Live Riyadh discussed the challenges facing lawyers advising on Saudi Arabia’s multibillion-dollar “giga projects” and the tools they might employ to avoid dispute escalation.
06 March 2025
An Australian-owned mining company has asked a US court to enforce an ICSID award requiring Colombia to reimburse it for overpaid royalties.
05 March 2025
An ICSID tribunal has refused to throw out a US$11 billion claim against Honduras over its repeal of special economic zones, rejecting arguments that the US claimant should have exhausted local remedies before turning to international arbitration.
28 February 2025
A task force set up by the International Bar Association’s arbitration committee has recommended the drafting of guidelines for an autonomous standard of res judicata to promote consistency in international commercial arbitration.
25 February 2025
Practitioners have welcomed the news that the UK has enacted long-awaited reforms to its three-decade-old arbitration law.
24 February 2025
In a keynote at GAR Live Riyadh, ICC Court president Claudia Salomon set out seven practical strategies for winning an international arbitration through written and oral advocacy.
24 February 2025
A Norwegian drilling rig company has won a US$105 million award against a Nigerian oil and gas group over alleged non-payment of their contract, after defeating a much larger counterclaim.
21 February 2025
A Pakistani venture capital firm has asked courts in the US and Pakistan to enforce a JAMS award preventing its founder from transferring his shares in the company after he resigned following allegations of sexual misconduct.
21 February 2025
The Court of Appeal in London has upheld a charge on a London property linked to Libya’s former leader Muammar Gaddafi, siding with a US defence contractor seeking to collect a £16 million ICC award against the state.
20 February 2025
Danish pharmaceutical group Novo Nordisk is preparing to launch an ICC arbitration worth US$830 million against a Singapore biosciences company for alleged fraud, after acquiring a hypertension drug that failed in clinical trials.
19 February 2025
Unlock unlimited access to all Global Arbitration Review content